Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCL) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Chs (CHSCL) over the last 11 years, with Q4 2025 value amounting to $4.2 million.

  • Chs' Asset Writedowns and Impairment rose 23480.5% to $4.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $13.4 million, marking a year-over-year increase of 64099.15%. This contributed to the annual value of $6.1 million for FY2025, which is 896.82% up from last year.
  • Per Chs' latest filing, its Asset Writedowns and Impairment stood at $4.2 million for Q4 2025, which was up 23480.5% from $101000.0 recorded in Q3 2025.
  • In the past 5 years, Chs' Asset Writedowns and Impairment registered a high of $10.1 million during Q1 2022, and its lowest value of -$18.5 million during Q1 2023.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $2.2 million (2021), whereas its average is $1.3 million.
  • Per our database at Business Quant, Chs' Asset Writedowns and Impairment plummeted by 587592.59% in 2021 and then skyrocketed by 26175.06% in 2022.
  • Quarter analysis of 5 years shows Chs' Asset Writedowns and Impairment stood at $1.5 million in 2021, then surged by 101.15% to $3.0 million in 2022, then soared by 69.17% to $5.0 million in 2023, then plummeted by 161.95% to -$3.1 million in 2024, then soared by 234.81% to $4.2 million in 2025.
  • Its Asset Writedowns and Impairment stands at $4.2 million for Q4 2025, versus $101000.0 for Q3 2025 and $9.5 million for Q2 2025.